Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
20398 | 400 | 39.8 | 67% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NICOTINE ABSTINENCE | Author keyword | 1 | 22% | 1% | 5 |
2 | MOL NEUROPSYCHOPHARMACOL | Address | 1 | 22% | 1% | 4 |
3 | ALLERGY AND HYPERSENSITIVITY | Author keyword | 1 | 50% | 0% | 1 |
4 | ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR NACHR | Author keyword | 1 | 50% | 0% | 1 |
5 | CHRONIC GRADED PAIN SCALE | Author keyword | 1 | 50% | 0% | 1 |
6 | CHRONIC MUSCULOSKELETAL COMPLAINTS | Author keyword | 1 | 50% | 0% | 1 |
7 | COMMUNITY PATIENTS WITH PAIN | Author keyword | 1 | 50% | 0% | 1 |
8 | DANSYL COMPOUNDS | Author keyword | 1 | 50% | 0% | 1 |
9 | FENTANYL CONSUMPTION | Author keyword | 1 | 50% | 0% | 1 |
10 | GLUTAMATE NMDA AND AMPA RECEPTORS | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NICOTINE ABSTINENCE SYNDROME | 2 | 44% | 1% | 4 |
2 | 57 408 ADOLESCENTS | 2 | 67% | 1% | 2 |
3 | PSYCHOACTIVE DRUG | 2 | 67% | 1% | 2 |
4 | NICOTINE INDUCED ANTINOCICEPTION | 2 | 24% | 2% | 6 |
5 | RELATIVE REINFORCING VALUE | 1 | 31% | 1% | 4 |
6 | ADMINISTERED CDP CHOLINE | 1 | 33% | 1% | 2 |
7 | 21 923 ADULTS | 1 | 50% | 0% | 1 |
8 | 24 H MEASUREMENTS | 1 | 50% | 0% | 1 |
9 | BRAIN EVOKED RESPONSES | 1 | 50% | 0% | 1 |
10 | CEREBRAL BENZODIAZEPINE RECEPTORS | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Opioid antagonists for smoking cessation | 2013 | 5 | 16 | 75% |
Smoking and Pain Pathophysiology and Clinical Implications | 2010 | 45 | 203 | 31% |
Opioid antagonists for smoking cessation | 2006 | 22 | 30 | 67% |
Neurobiological mechanisms involved in nicotine dependence and reward: Participation of the endogenous opioid system | 2010 | 36 | 187 | 25% |
Understanding the relationship between smoking and pain | 2013 | 4 | 73 | 29% |
Tobacco/nicotine and endogenous brain opioids | 2008 | 15 | 87 | 49% |
Activation of the opioid mu 1, but not delta or kappa, receptors is required for nicotine reinforcement in a rat model of drug self-administration | 2011 | 10 | 78 | 40% |
NEURO-ENDOCRINE ACTIONS OF NICOTINE AND OF EXPOSURE TO CIGARETTE-SMOKE - MEDICAL IMPLICATIONS | 1989 | 108 | 63 | 35% |
Nicotine and endogenous opioids: Neurochemical and pharmacological evidence | 2011 | 25 | 217 | 16% |
Endogenous Cannabinoid and Opioid Systems and their Role in Nicotine Addiction | 2010 | 12 | 112 | 24% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL NEUROPSYCHOPHARMACOL | 1 | 22% | 1.0% | 4 |
2 | SHANGDONG PROV OWNED HOSP | 1 | 50% | 0.3% | 1 |
3 | SUBST ABUSESUBST ABUSE | 1 | 50% | 0.3% | 1 |
4 | ADULT HLTH ILLNESS NURSING | 0 | 33% | 0.3% | 1 |
5 | CONSULTAT PATHOL ENVIRONM MARITIMES PROFESS | 0 | 33% | 0.3% | 1 |
6 | STUDY CHRON COMORBID MED PSYCHIAT DISORDERS | 0 | 33% | 0.3% | 1 |
7 | NEUROL PSYCHIAT BEHAV SCI | 0 | 25% | 0.3% | 1 |
8 | ORAL MAXILLO IAL SURG ORAL DIAGNOST SC | 0 | 25% | 0.3% | 1 |
9 | SERV MED TRAVAIL PERSONNEL HOSP | 0 | 25% | 0.3% | 1 |
10 | CIENCIAS SALUT VIDA | 0 | 12% | 0.5% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000138487 | NICOTINE//ALPHA 7//NICOTINIC RECEPTOR |
2 | 0.0000134944 | TRANSDERMAL NICOTINE//CHRNA4//BRAIN IMAGING PROGRAM |
3 | 0.0000130153 | ALCOHOL AND TOBACCO//CHANTIX//CESSATION OF AODU |
4 | 0.0000115059 | EHCSS//HPHC//MOUTH LEVEL EXPOSURE |
5 | 0.0000095687 | SALVINORIN A//SALVIA DIVINORUM//KAPPA OPIOID RECEPTOR |
6 | 0.0000095539 | LOAD CARRIAGE//BACKPACK//SCHOOLBAG |
7 | 0.0000080752 | CIGARETTE CRAVINGS//WEIGHT CONCERNS//THERMAL EFFECT OF SMOKING |
8 | 0.0000077682 | TAIL FLICK INHIBITION//BETA ENDORPHIN 1 27//LEUCOPYROKININ |
9 | 0.0000077316 | PLASMA SPRAYED TITANIUM IMPLANTS//REMOVAL TORQUE TEST//CIGARETTE SMOKE MEDIUM |
10 | 0.0000077044 | NICOTINE DEPENDENCE//PROGRAM SMOKERS MENTAL ILLNESS//ADDICT PSYCHIAT |